Q4 2019 Holdings
Filed 2020-05-18 | 64 holdings | $47.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anaptysbio Inc(ANAB) | COM | 032724106 | $163 | 10,000 | 0.0% |
| Zealand Pharma A S | SPONSORED ADR | 98920Y304 | $188 | 5,653 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $296 | 11,200 | 0.0% |
| Radius Health Inc | COM | 750469207 | $342 | 17,000 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $402 | 11,295 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $454 | 30,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $473 | 19,953 | 0.0% |
| Akcea Therapeutics Inc(AKCAEUR) | COM | 00972L107 | $536 | 31,723 | 0.0% |
| Myriad Genetics inc(MYGN) | COM | 62855J104 | $680 | 25,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $749 | 16,500 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $801 | 33,600 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $845 | 19,700 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $869 | 220,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $920 | 94,600 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $967 | 13,500 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $989 | 10,700 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $1.1K | 17,000 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.1K | 10,200 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $1.2K | 177,825 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.3K | 22,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.4K | 17,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $1.4K | 37,000 | 0.0% |
| Globus Med Inc(GMED) | COM | 379577208 | $1.4K | 24,200 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $1.5K | 17,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.5K | 139,331 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $1.6K | 80,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $1.8K | 30,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.8K | 103,534 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $1.8K | 23,100 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.2K | 35,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $2.2K | 30,000 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $2.2K | 42,700 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $2.5K | 303,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.0K | 41,400 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $3.0K | 35,500 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $3.0K | 140,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.0K | 57,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.2K | 53,781 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.6K | 35,900 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.9K | 277,433 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $5.2K | 40,100 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $5.5K | 307,633 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $5.5K | 114,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.6K | 64,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $7.3K | 64,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $7.5K | 83,000 | 0.0% |
| Amarin Corp Plc | SPONS ADR NEW | 023111206 | $8.3K | 388,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $8.3K | 25,100 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $9.3K | 86,141 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $10.3K | 965,245 | 0.0% |